Depletion of CD4+and CD8+Cells Eliminates Immunologic Memory of Thyroiditogenicity in Murine Experimental Autoimmune Thyroiditis
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 19 (3) , 161-168
- https://doi.org/10.3109/08916939408995691
Abstract
Experimental autoimmune thyroiditis (EAT) develops in genetically susceptible mice after immunization with mouse thyroglobulin (MTg), and is mediated by T cells, both CD4+ and CD8+, infiltrating the thyroid. Previous work showed that depletion of CD4 +, but not CD8 +, cells with rat monoclonal antibodies (mAbs) interfered with EAT induction. To test if concomitant CD4 + cell depletion and immunization led to EAT resistance, mice were reimmunized at an interval of 15 or 43 days after injection of CD4 mAbs. No resistance had been established; disease severity and anti-MTg titers were comparable to mice with primary immunization. Previous work also showed that treatment during advancing EAT with only CD4 mAbs on days 21, 25 led to long-lasting, reduced severity in EAT, whereas administration of CD8 mAbs alone reduced the smaller CD8 + subset only. However, therapy with both mAbs was most efficacious; > 50% of thyroids were purged of all cellular infiltrate after only two doses. Moreover, T cells emerging subsequent to depletion were not retained in the thyroid, despite ongoing antibody production. To test if nondepleting CD4 and CD8 mAbs were similarly effective for therapy, mAbs of the IgG2a isotype were administered during advancing EAT. No effect on thyroidal infiltration was observed, indicating that modulation of the CD4 and CD8 antigen without depletion was insufficient for efficacious therapy. To determine if combined therapy with depleting mAbs reestablished self tolerance, treated mice were reimmunized on days 70, 77, when T cell recovery was nearly complete. Thyroiditis was comparable to controls given primary immunization, despite high antibody levels. Thus, efficient depletion of both T cell subsets eliminated immunologic memory of thyroiditogenicity and represents a suitable treatment modality for autoimmune disease.Keywords
This publication has 37 references indexed in Scilit:
- In situ analysis of T cell subset composition in experimental autoimmune thyroiditis after adoptive transfer of activated spleen cellsCellular Immunology, 1990
- Depletion of L3T4+ and Lyt-2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditisCellular Immunology, 1989
- Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulinsClinical Immunology and Immunopathology, 1986
- Characterization of the in vitro murine T-cell proliferative responses to murine and human thyroglobulins in thyroiditis-susceptible and -resistant miceCellular Immunology, 1985
- Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cellsCellular Immunology, 1985
- Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cellsCellular Immunology, 1985
- Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers.The Journal of Experimental Medicine, 1983
- In vitro T-lymphocyte proliferative response to mouse thyroglobulin in experimental autoimmune thyroiditisCellular Immunology, 1981
- Syngeneic thyroglobulin is immunogenic in good responder miceEuropean Journal of Immunology, 1981
- Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide.The Journal of Experimental Medicine, 1977